|
|
Press Releases
| All 2004 Releases |
|---|
 |
Osiris Therapeutics, Inc. Strengthens Executive Team.
12-17-04
8.9 KB
|
| |
Baltimore, Maryland - December 16, 2004 -- Osiris Therapeutics, the leader in adult stem cell therapy, is pleased to announce the addition of Cary Claiborne as Chief Financial Officer and Harry Carmitchel as Chief Operating Officer.
"We are very pleased to be joined by two such talented and accomplished individuals", said C....
|
|
Stem Cell Therapy Effectively Treats Heart Attacks in Animals
11-09-04
11.7 KB
|
| |
Results from an animal study conducted at Johns Hopkins show that stem cell therapy can be used effectively to treat heart attacks, or myocardial infarcts, in pigs. Stem cells taken from another pig's bone marrow, when injected into the animal's damaged heart, were able to restore the heart's function to its original condition.
|
| |
Researchers Turn To Adult Stem Cells
08-08-04
588.6 KB
|
|
Osiris Therapeutics appoints C. Randal Mills President and Chief Executive Officer
06-06-04
8.1 KB
|
| |
Osiris Therapeutics, the leader in adult stem cell therapy, is pleased to announce that its Board of Directors has appointed C. Randal Mills President and Chief Executive Officer to lead the company effective July 5, 2004. In addition to President and CEO, Dr. Mills was also elected to the Board of Directors.
Dr. Mills was re...
|
| Showing 1-4 of 4 releases |
Page: 1 |
|
|
|
 |
Stock Information
OSIR - (NASDAQ)
$6.57
+ 0.09
|
11-20-09
4:11 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
|
|
|
|
|
Shareholder Tools
|
|
